Special ReportsAll NewsFDA BriefsOncology IconsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesEvolving Paradigms in OncologyExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPersonalized MedicinePivotal Practice Views with the Oncology BrothersPodcastsSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsEventsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2 Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE
Advertisement

Evolving NSCLC Treatment Paradigm

home / investigator-perspectives / evolving-treatment-nsclc

Lung Cancer


Pathology of Stage IV Lung Adenocarcinoma

EP. 1: Pathology of Stage IV Lung Adenocarcinoma

August 23rd 2018

Watch


Molecular Testing in Stage IV Lung Cancer

EP. 2: Molecular Testing in Stage IV Lung Cancer

August 23rd 2018

Watch


Emerging Predictive Biomarkers in NSCLC

EP. 3: Emerging Predictive Biomarkers in NSCLC

August 23rd 2018

Watch


Frontline Therapy for EGFR Plus NSCLC: Osimertinib's Impact

EP. 4: Frontline Therapy for EGFR Plus NSCLC: Osimertinib's Impact

August 23rd 2018

Watch


ALK/ROS1-Rearranged NSCLC: Approaching Therapy

EP. 5: ALK/ROS1-Rearranged NSCLC: Approaching Therapy

August 23rd 2018

Watch


Sequencing Therapy in ALK/ROS1-Rearranged NSCLC

EP. 6: Sequencing Therapy in ALK/ROS1-Rearranged NSCLC

August 23rd 2018

Watch


Treatment of BRAF-Mutant NSCLC

EP. 7: Treatment of BRAF-Mutant NSCLC

August 23rd 2018

Watch


Benefit of Pembrolizumab in NSCLC: The KEYNOTE Trials

EP. 8: Benefit of Pembrolizumab in NSCLC: The KEYNOTE Trials

August 23rd 2018

Watch


Chemo-Immunotherapy in NSCLC: The KEYNOTE-189 Trial

EP. 9: Chemo-Immunotherapy in NSCLC: The KEYNOTE-189 Trial

August 23rd 2018

Watch


IMpower150: Combining VEGF and I-O Therapy in NSCLC

EP. 10: IMpower150: Combining VEGF and I-O Therapy in NSCLC

August 23rd 2018

Watch


Dual Checkpoint Inhibition in NSCLC: CheckMate-227

EP. 11: Dual Checkpoint Inhibition in NSCLC: CheckMate-227

August 23rd 2018

Watch


Considering Use of I-O Therapy in Driver Mutation NSCLC

EP. 12: Considering Use of I-O Therapy in Driver Mutation NSCLC

August 23rd 2018

Watch


Trials of I-O Therapy in Driver Mutation NSCLC

EP. 13: Trials of I-O Therapy in Driver Mutation NSCLC

August 23rd 2018

Watch


Driver Mutation NSCLC: Combining Targeted and I-O Therapy

EP. 14: Driver Mutation NSCLC: Combining Targeted and I-O Therapy

August 23rd 2018

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Editorial Board
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.